Organovo Logo     Print Page | Close Window

Investor Overview

Who is Organovo?
  • We participate in attractive and growing markets with critical unmet needs
  • We benefit from favorable competitive dynamics and a first mover advantage
  • We’re a technology leader with a strong IP portfolio
  • We’re leveraging our technology platform to build a robust product and service platform across the preclinical safety, efficacy and disease modeling and therapeutic tissues markets
2016 Annual Report Investor Fact Sheet Investor Presentation

Stock Information
ONVO (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$2.94
Change (%) + 0.09 (3.16%)
Volume1,062,687
Data provided by Nasdaq. Minimum 15 minutes delayed.
Stock chart for: ONVO.O.  Currently trading at $2.94 with a 52 week high of $4.99 and a 52 week low of $2.48.
Recent Investor News
05/18/17
Organovo Presents New Preclinical Data on 3D Bioprinted Human Liver Tissues at World Advanced Therapies and Regenerative Medicine Congress
05/17/17
Organovo Announces Release Date for Fiscal Fourth-Quarter 2017 Financial Results
Investor Events
Wednesday, June 7, 2017 5:00 p.m. ET
Organovo Holdings, Inc. Fourth Quarter Earnings Conference Call
Featured Reports
2016 Annual Report
2016 Proxy Statement
Latest Tweets